Pay in 4 interest-free payments of $7.49 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
AOD-9604 Adolescent (12 to 17) Dosing: What Clinicians and Parents Need to Know At a glance Regulatory status / No FDA approval for any indication or age group Typical research dose in adults / 250 to 500 mcg subcutaneous once daily (not validated in adolescents) Adolescent trial evidence / Zero published RCTs in the 12, 17 age group Key safety concern / Potential interference with growth-plate biology and pubertal GH axis Compounding status / Available only through 503A compounding pharmacies under prescriber order Primary preclinical evidence / Heffernan et al
*Product contains benzyl alcohol as an inactive ingredient Contraindications for Benzyl Alcohol This preparation is not advised in patients who are sensitive to cobalt and/or vitamin B12
Unusual smell when opening the vial
Some research suggests it may have potential benefits for wound healing and tissue repair
US$ 20.70
US$ 28.58
US$ 23.76
US$ 28.05
